U.S. Blacklists Y Combinator's China Spinoff and Firms Linked to Google AI Trade Secret Theft
nashnova research
The U.S. State Department blacklisted Shanghai Zhisuan Technology and MiraclePlus (formerly Y Combinator China) under the Protecting American Intellectual Property Act (PAIPA). This means → the U.S.–China AI decoupling now reaches beyond chips into startup incubators and early-stage venture capital, threatening several companies preparing for Hong Kong IPOs.
Who got sanctioned, and under what authority?
The State Department placed Shanghai Zhisuan Technology and MiraclePlus (奇绩创坛) on the sanctions blacklist, along with three MiraclePlus-managed funds.
The legal basis is PAIPA — a 2023 law targeting foreign entities that benefit from the theft of U.S. trade secrets.
Per Bloomberg, consequences may include freezing U.S. assets and restricting banking access.
What is the theft chain at the center of this?
Shanghai Zhisuan was founded by Linwei Ding (丁林威), a former Google engineer convicted of stealing core technical documents on Google's AI supercomputing infrastructure before leaving the company.
The State Department said Ding pitched MiraclePlus's incubator by touting his access to Google's technology, claiming he could replicate Google's "superintelligence" infrastructure and adapt it for China.
This means → Washington's logic chain is: theft → fundraising on stolen IP → incubator funds the venture for equity — and every link in that chain faces consequences.
What is MiraclePlus, and who is behind it?
MiraclePlus was founded by Lu Qi (卢奇), a former Microsoft executive who ran Bing, Office, and Skype, and later served as Baidu's group president and COO — a rare executive who has held senior roles on both sides of the U.S.–China tech divide.
In 2018, then-Y Combinator president Sam Altman personally recruited Lu to lead YC China, calling the country "a key missing piece" of YC's puzzle.
When YC shut its China operations in 2019 amid trade-war tensions, Lu spun the team out as MiraclePlus, keeping the YC playbook: ~$300,000 per deal for 7% equity, two batches a year.
How hard does this hit companies heading for a Hong Kong IPO?
MiraclePlus's portfolio includes AI inference platform SiliconFlow (硅基流动) and robotics maker AgiBot (智元机器人), both of which are considering a Hong Kong listing.
In plain terms = "investor under U.S. sanctions" is not a line any underwriter wants in a prospectus — it is a visible red flag for institutional buyers.
Whether the sanctions will materially block the IPO process is the key variable the market is watching next.
How has MiraclePlus responded?
MiraclePlus denied ever investing in Shanghai Zhisuan, saying the sanctions were imposed "without any prior communication."
The company said it is in talks with relevant parties, hoping to resolve the matter through "frank communication."
This reflects a fundamental dispute: Washington says the incubation relationship existed; MiraclePlus says the investment never happened — the two sides directly contradict each other on the basic facts.
市场有风险，内容仅供研究参考，不构成投资建议。